-
Oracle, Dow, Uber And A Financial Stock On CNBC's 'Final Trades'
Wednesday, February 11, 2026 - 8:55am | 448Read More...On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, named Uber Technologies, Inc. (NYSE:UBER) as his final trade. According to recent reports, on Feb. 9, Uber announced a strategic agreement to acquire Getir's delivery portfolio in...
-
Amazon, Transocean, Interactive Brokers And More On CNBC's 'Final Trades'
Tuesday, February 10, 2026 - 9:22am | 512Read More...On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, named Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL) as her final trade. Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners,...
-
Zoom, Kinsale Capital, Palantir And A Health Care Stock On CNBC's 'Final Trades'
Friday, February 6, 2026 - 9:26am | 461Read More...On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, said Zoom Communications, Inc. (NASDAQ:ZM) has high free cash flow. Zoom, on Nov. 24, posted third-quarter revenue of $1.23 billion. It beat the consensus estimate of $1.21...
-
Amcor, Emerson Electric And More: CNBC's 'Final Trades'
Thursday, February 5, 2026 - 9:35am | 429Read More...On CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, picked the iShares Biotechnology ETF (NYSE:IBB), and recommended staying long on biotech. Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset...
-
Exxon Mobil, Hubbell, Rockwell Automation And More On CNBC's 'Final Trades'
Wednesday, February 4, 2026 - 8:44am | 457Read More...On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said Exxon Mobil Corporation (NYSE:XOM) hit a new 52-week high on Tuesday. Supporting his view, TD Cowen analyst Jason Gabelman, on Tuesday, maintained Exxon Mobil with a Buy and...
-
Raymond James, Vulcan Materials And More On CNBC's 'Final Trades'
Tuesday, February 3, 2026 - 8:44am | 401Read More...On CNBC's “Halftime Report Final Trades,” Brian Belski, CEO at Humilis Investment Strategies, named Raymond James Financial, Inc. (NYSE:RJF) as his final trade. On the earnings front, Raymond James, on Jan. 28, reported quarterly earnings of $2.86 per share. It missed the analyst...
-
Synopsys, Rocket Companies, On Holding And A Health Care Stock On CNBC's 'Final Trades'
Monday, February 2, 2026 - 9:08am | 448Read More...On CNBC's “Halftime Report Final Trades,” Hightower Advisors’ Stephanie Link picked Synopsys, Inc. (NASDAQ:SNPS) as her final trade. Sunnyvale, California-based Synopsys is scheduled to report results for the first quarter on Wednesday, Feb. 25, after the closing bell. Analysts...
-
GE Vernova, Amazon And A Tech Stock On CNBC's 'Final Trades'
Thursday, January 29, 2026 - 8:54am | 443Read More...On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, recommended buying GE Vernova Inc. (NYSE:GEV). GE Vernova, on Wednesday, reported mixed fourth-quarter results. For the quarter, the company reported revenue of $10.956 billion,...
-
BlackRock, Thermo Fisher And More On CNBC's 'Final Trades'
Tuesday, January 27, 2026 - 8:51am | 387Read More...On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner at Cerity Partners, named BlackRock, Inc. (NYSE:BLK) as his final trade. BlackRock, on Jan. 15, reported better-than-expected fourth-quarter financial results and raised its quarterly dividend. Revenue grew 23% year-over-...
-
Kimberly Clark, S&P Global, Exxon Mobil And A Health Care Stock On CNBC's 'Final Trades'
Friday, January 23, 2026 - 8:47am | 431Read More...On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner at Cerity Partners, said Vertex Pharmaceuticals (NASDAQ:VRTX) has nice little chart here over the last few months, up around 30% and expects it to continue. Lending support to his choice, RBC Capital analyst Brian Abrahams...
-
Alibaba, IBM, Nu Holdings And More: CNBC's 'Final Trades'
Thursday, January 22, 2026 - 9:10am | 458Read More...On CNBC's “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, said International Business Machines Corporation (NYSE:IBM) is expected to report good earnings next week. IBM is scheduled to report quarterly earnings on Jan. 28. Analysts...
-
Toast, Southern And More On CNBC's 'Final Trades'
Wednesday, January 21, 2026 - 9:10am | 385Read More...On CNBC's “Halftime Report Final Trades,” Ritholtz Wealth Management CEO Joshua Brown reiterated his buy action on Toast, Inc. (NYSE:TOST), adding that he likes the price action on Tuesday. Oppenheimer analyst Rayna Kumar, on Jan. 12, maintained Toast with an Outperform rating and...
-
Jim Cramer Says Sell Super Micro — Calls A European Chipmaker 'Cheap And Good'
Tuesday, January 20, 2026 - 10:02am | 614Read More...On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended selling Super Micro Computer, Inc. (NASDAQ:SMCI), adding he doesn't need that. Supporting his view, Goldman Sachs analyst Katherine Murphy assumed coverage of Super Micro Computer on Jan. 13, assigning a Sell rating and...
-
Wells Fargo, Baker Hughes, Honda Motor And More On CNBC's 'Final Trades'
Tuesday, January 20, 2026 - 9:13am | 451Read More...On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, named Baker Hughes Company (NASDAQ:BKR) as his final trade. Supporting his view, Susquehanna analyst Charles Minervino maintained a Positive rating on Baker Hughes on Jan. 7 and...
-
Jim Cramer: This Industrial Stock Is A Buy, Recommends Staying Away From Enterprise Software Companies
Friday, January 16, 2026 - 9:24am | 539Read More...On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Banco Santander, S.A. (NYSE:SAN), saying it is “terrific.” As per the recent news, Banco Santander, on Jan. 9, sold a 49% stake in Polish subsidiary to Erste Group. Cramer recommended to stay away from...
















